James Mauldin is a Littleton, Colorado based psychiatrist who is specialized in Psychiatry. His current practice location is 10789 Bradford Rd, Ste 204, Littleton. Patients can reach him at 303-951-3765 or can fax him at 303-951-3764. James Mauldin is MD in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1619191012. James Mauldin specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
James Mauldin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1619191012
NPI Enumeration Date:
13 Apr, 2007
NPI Last Update On:
12 Aug, 2022
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
James Mauldin 10789 Bradford Rd, Ste 204 Littleton, Colorado
Zip:
80127-6406
Phone Number:
303-951-3765
Fax Number:
303-951-3764
Patients can reach James Mauldin at 10789 Bradford Rd, Ste 204, Littleton, Colorado or can call to book an appointment on 303-951-3765.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.